{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:48:47Z","timestamp":1791578927263,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82120108005"],"award-info":[{"award-number":["82120108005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JJ40085"],"award-info":[{"award-number":["2025JJ40085"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023JJ30760"],"award-info":[{"award-number":["2023JJ30760"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.intimp.2026.117498","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:35:54Z","timestamp":1791041754000},"page":"117498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Deficiency of purinergic receptor P2X7 attenuates neointima hyperplasia in mice after carotid artery wire injury"],"prefix":"10.1016","volume":"190","author":[{"given":"Zhongchen","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maohua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lunchang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiehua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117498_bb0005","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.jacc.2014.02.545","article-title":"Current treatment of in-stent restenosis","volume":"63","author":"Alfonso","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2026.117498_bb0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jacc.2022.05.017","article-title":"Coronary in-stent restenosis: JACC state-of-the-art review","volume":"80","author":"Giustino","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2026.117498_bb0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11886-025-02193-z","article-title":"From mechanisms to management: tackling in-stent restenosis in the drug-eluting stent era","volume":"27","author":"Spadafora","year":"2025","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.intimp.2026.117498_bb0020","first-page":"213","article-title":"Neointimal hyperplasia","volume":"26","author":"Braga","year":"2019","journal-title":"Rev. Port. Cir. Cardiotorac. Vasc."},{"key":"10.1016\/j.intimp.2026.117498_bb0025","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.biotechadv.2018.04.006","article-title":"Vascular smooth muscle cell proliferation as a therapeutic target. Part 1: molecular targets and pathways","volume":"36","author":"Wang","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.intimp.2026.117498_bb0030","doi-asserted-by":"crossref","DOI":"10.1177\/00033197251413811","article-title":"Molecular factors involved in the mechanism of intimal hyperplasia: a systematic review","author":"Indriani","year":"2026","journal-title":"Angiology"},{"key":"10.1016\/j.intimp.2026.117498_bb0035","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jcin.2011.05.025","article-title":"Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis","volume":"4","author":"Inoue","year":"2011","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.intimp.2026.117498_bb0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41569-019-0265-3","article-title":"Transcriptional and epigenetic regulation of macrophages in atherosclerosis","volume":"17","author":"Kuznetsova","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.intimp.2026.117498_bb0045","article-title":"Artesunate inhibits neointimal hyperplasia by promoting IRF4 associated macrophage polarization","volume":"12","author":"Miao","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.intimp.2026.117498_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2017.06.020","article-title":"The P2X7 receptor in infection and inflammation","volume":"47","author":"Di Virgilio","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.117498_bb0055","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/ATVBAHA.120.315116","article-title":"P2X7 receptors: an untapped target for the management of cardiovascular disease","volume":"41","author":"Shokoples","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2026.117498_bb0060","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1038\/s41598-017-05137-y","article-title":"P2X7 receptor antagonism modulates IL-1\u03b2 and MMP9 in human atherosclerotic vessels","volume":"7","author":"Lombardi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.117498_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yjmcc.2019.12.011","article-title":"Cathelicidin aggravates myocardial ischemia\/reperfusion injury via activating TLR4 signaling and P2X(7)R\/NLRP3 inflammasome","volume":"139","author":"Wu","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117498_bb0070","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s11302-024-10009-y","article-title":"P2X7 receptor is essential for ST36-attenuated cardiac fibrosis upon beta-adrenergic insult","volume":"21","author":"Zhang","year":"2025","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.intimp.2026.117498_bb0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00281-023-00987-3","article-title":"The role of the ATP-adenosine axis in ischemic stroke","volume":"45","author":"Sch\u00e4dlich","year":"2023","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.intimp.2026.117498_bb0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.trsl.2023.03.002","article-title":"Purinergic receptor P2X7 contributes to abdominal aortic aneurysm development via modulating macrophage pyroptosis and inflammation","volume":"258","author":"Sun","year":"2023","journal-title":"Transl. Res."},{"key":"10.1016\/j.intimp.2026.117498_bb0085","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1161\/CIRCULATIONAHA.117.027400","article-title":"P2X(7) deficiency blocks lesional inflammasome activity and ameliorates atherosclerosis in mice","volume":"135","author":"Stachon","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2026.117498_bb0090","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1161\/ATVBAHA.115.305789","article-title":"HMGB1-driven inflammation and intimal hyperplasia after arterial injury involves cell-specific actions mediated by TLR4","volume":"35","author":"Cai","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2026.117498_bb0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2119\/molmed.2016.00222","article-title":"Cathepsin L promotes vascular intimal hyperplasia after arterial injury","volume":"23","author":"Cai","year":"2017","journal-title":"Mol. Med."},{"key":"10.1016\/j.intimp.2026.117498_bb0100","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1021\/jm051202e","article-title":"Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists","volume":"49","author":"Nelson","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2026.117498_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1340405","article-title":"Inflammasome modulation with P2X7 inhibitor A438079-loaded dressings for diabetic wound healing","volume":"15","author":"Yaron","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117498_bb0110","article-title":"Interleukin 6-regulated macrophage polarization controls atherosclerosis-associated vascular intimal hyperplasia","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117498_bb0115","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3892\/ijmm.2015.2129","article-title":"P2X7R is involved in the progression of atherosclerosis by promoting NLRP3 inflammasome activation","volume":"35","author":"Peng","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2026.117498_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117470","article-title":"MTMR7 suppresses the phenotypic switching of vascular smooth muscle cell and vascular intimal hyperplasia after injury via regulating p62\/mTORC1-mediated glucose metabolism","volume":"390","author":"Sun","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2026.117498_bb0125","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/bph.17436","article-title":"Smooth muscle cell Piezo1 is essential for phenotypic switch and neointimal hyperplasia","volume":"182","author":"Zhang","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117498_bb0130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.122.060860","article-title":"NLRP3 inflammasome activation through heart-brain interaction initiates cardiac inflammation and hypertrophy during pressure overload","volume":"147","author":"Higashikuni","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2026.117498_bb0135","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2026.117498_bb0140","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.intimp.2026.117498_bb0145","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41569-023-00946-3","article-title":"The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases","volume":"21","author":"Toldo","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.intimp.2026.117498_bb0150","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.117498_bb0155","article-title":"P2X7 receptor-mediated inflammation in cardiovascular disease","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117498_bb0160","article-title":"Berberine regulated miR150-5p to inhibit P2X7 receptor, EMMPRIN and MMP-9 expression in oxLDL induced macrophages","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117498_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ph15010089","article-title":"P2X7 receptor antagonist reduces fibrosis and inflammation in a mouse model of alpha-Sarcoglycan muscular dystrophy","volume":"15","author":"Raffaghello","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.intimp.2026.117498_bb0170","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural mechanisms of NLRP3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.117498_bb0175","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1093\/eurheartj\/ehaf337","article-title":"Smooth muscle cells in atherosclerosis: essential but overlooked translational perspectives","volume":"46","author":"Azar","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.intimp.2026.117498_bb0180","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1152\/physrev.00003.2017","article-title":"Vascular smooth muscle cells and arterial stiffening: relevance in development, aging, and disease","volume":"97","author":"Lacolley","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2026.117498_bb0185","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2026.117498_bb0190","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-022-00993-2","article-title":"How vascular smooth muscle cell phenotype switching contributes to vascular disease","volume":"20","author":"Cao","year":"2022","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.intimp.2026.117498_bb0195","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142339","article-title":"Therapeutic MK2 inhibition blocks pathological vascular smooth muscle cell phenotype switch","volume":"6","author":"Tierney","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2026.117498_bb0200","doi-asserted-by":"crossref","first-page":"16314","DOI":"10.1074\/jbc.RA120.015486","article-title":"TL1A inhibits atherosclerosis in apoE-deficient mice by regulating the phenotype of vascular smooth muscle cells","volume":"295","author":"Zhao","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.117498_bb0205","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00018-023-04883-9","article-title":"SMYD2 regulates vascular smooth muscle cell phenotypic switching and intimal hyperplasia via interaction with myocardin","volume":"80","author":"Zhou","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2026.117498_bb0210","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1093\/cvr\/cvad080","article-title":"Protein arginine methyltransferase 5-mediated arginine methylation stabilizes Kruppel-like factor 4 to accelerate neointimal formation","volume":"119","author":"Liu","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2026.117498_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.597423","article-title":"Reversal of endothelial extracellular vesicle-induced smooth muscle phenotype transition by hypercholesterolemia stimulation: role of NLRP3 inflammasome activation","volume":"8","author":"Yuan","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2026.117498_bb0220","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0140-6736(15)60657-2","article-title":"Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis","volume":"386","author":"Siontis","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2026.117498_bb0225","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11886-025-02249-0","article-title":"In-stent restenosis: incidence, mechanisms, and treatment options","volume":"27","author":"Sola","year":"2025","journal-title":"Curr. Cardiol. Rep."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926013469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:49:47Z","timestamp":1791575387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926013469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":45,"alternative-id":["S1567576926013469"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117498","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deficiency of purinergic receptor P2X7 attenuates neointima hyperplasia in mice after carotid artery wire injury","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117498","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117498"}}